Alpha Cognition Inc. (ACOG)
NASDAQ: ACOG · Real-Time Price · USD
6.91
+0.23 (3.44%)
At close: Jun 18, 2026, 4:00 PM EDT
6.73
-0.18 (-2.60%)
After-hours: Jun 18, 2026, 4:53 PM EDT
Alpha Cognition Employees
Alpha Cognition had 71 employees as of December 31, 2025. The number of employees increased by 14 or 24.56% compared to the previous year.
Employees
71
Change (1Y)
14
Growth (1Y)
24.56%
Revenue / Employee
$152,471
Profits / Employee
-$358,068
Market Cap
150.46M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 71 | 14 | 24.56% | 71 | 0 |
| Dec 31, 2024 | 57 | - | - | 52 | 5 |
Related Stocks
| Company Name | Employees |
|---|---|
| Molecular Partners AG | 134 |
| Caribou Biosciences | 97 |
| Tenaya Therapeutics | 70 |
| Acumen Pharmaceuticals | 61 |
| Corbus Pharmaceuticals Holdings | 36 |
| Enlivex | 34 |
| Spruce Biosciences | 14 |
| Tiziana Life Sciences | 10 |
ACOG News
- 3 days ago - Alpha Cognition announces enrollment of first patient in Resolve - TheFly
- 3 days ago - Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer's Disease - Business Wire
- 10 days ago - Alpha Cognition reports results from Beacon real-world study of Zunevyl - TheFly
- 10 days ago - Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer's Disease - Business Wire
- 21 days ago - Maxim starts Alpha Cognition at Buy, sees ‘significant’ market opportunity - TheFly
- 21 days ago - Alpha Cognition initiated with a Buy at Maxim - TheFly
- 4 weeks ago - Alpha Cognition Slides: Corporate presentation - Filings
- 5 weeks ago - Alpha Cognition reports Q1 EPS (32c) vs (11c) last year - TheFly